ACE genotype and endothelium-dependent vasodilation of conduit arteries and forearm microcirculation in humans

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 8, 2001, Pages 1313-1319

  Arcaro, Guido ^a   Solini, Anna ^c   Monauni, Tiziano ^a   Cretti, Anna ^a   Brunato, Barbara ^a   Lechi, Alessandro ^a   Fellin, Renato ^c   Caputo, Marco ^b   Cocco, Claudio ^b   Bonora, Enzo ^a   Muggeo, Michele ^a   Bonadonna, Riccardo C ^a,d  

^a UNIVERSITY OF VERONA   (Italy)

^b Verona City Hospital   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

ACE angiotensin receptors; Cardiovascular disease; Endothelium vascular type nitric oxide

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCERYL TRINITRATE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ALLELE; ARTERY DISEASE; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; DIAGNOSTIC TEST; DNA POLYMORPHISM; DOPPLER ECHOGRAPHY; ENDOTHELIUM; FEMALE; FEMORAL ARTERY; FOREARM BLOOD FLOW; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; PHENOTYPE; PRIORITY JOURNAL; VASODILATATION;

EID: 0035572898     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq0801.093508     Document Type: Article

References (46)

1. The angiotensin converting enzyme
2. An insertion/deletion polymorphism in the angiotensin I-converting enzyme (ACE) gene accounting for half the variance of serum enzyme levels
3. The biology of angiotensin II receptors
4. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice
5. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease
6. Elevated serum angiotensin I converting enzyme activity in type I, insulin-dependent diabetic subjects with persistent microalbuminuria
7. The angiotensin-converting enzyme gene and its inhibition in diabetic nephropathy
8. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
9. The deletion/insertion polymorphism of the angiotensin-converting enzyme gene and cardiovascular-renal risk
10. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy
11. Angiotensin converting enzyme gene polymorphism and cardiovascular disease
12. ACE Gene polymorphism in cardiovascular disease: Meta-analyses of small and large studies in whites
13. Genetically complex cardiovascular traits: Origins, problems, and potential solutions
14. Atherosclerosis, basic mechanisms: Oxidation, inflammation, and genetics
15. Endothelial dysfunctions: Common denominators in vascular disease
16. Atherosclerosis: An inflammatory disease
17. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
18. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium
19. Kinins and endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries
20. Vascular renin angiotensin system and neurotransmission in hypertensive persons
21. Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors
22. Angiotensin-converting enzyme gene polymorphism is associated with endothelium-dependent vasodilation in never treated hypertensive patients
23. DD Angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans
24. The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm
25. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin
26. Non-invasive detection of functional alterations of the arterial wall in insulin-dependent diabetic patients with and without microalbuminuria
27. Angiotensin converting enzyme inhibitors improve endothelial function in type I (insulin-dependent) diabetic patients with normal arterial pressure and microalbuminuria
28. Transmembrane glucose transport in skeletal muscle of patients with non-insulin dependent diabetes
29. Role of tissue specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle
30. Polymorphisms of angiotensin-converting enzyme and angiotensinogen genes in type 2 diabetic sibships in relation to albumin excretion rate
31. The deletion polymorphism of the angiotensin converting enzyme gene is related to phenotypic differences in human arteries
32. Endothelial function and vasodilator profile of the inferior epigastric artery
33. Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts
34. Angiotensin I to angiotensin II conversion in the human forearm and leg: Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism
35. A-receptor antagonist
36. Role of prostanoids in renin-dependent and renin-independent hypertension
37. Angiotensin II and the heart: On the intracrine renin-angiotensin system
38. Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension
39. Angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral arterial occlusive disease
40. Angiotensin converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND (Trial on Reversing Endothelial Dysfunction) Study
41. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure
42. Human peripheral endothelial dysfunction and nitric oxide bioavailability improves with angiotensin converting enzyme inhibition
43. ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients
44. Sequence variation in the human angiotensin converting enzyme